Mirae Asset Global Etfs Holdings Ltd. Lyell Immunopharma, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 312,406 shares of LYEL stock, worth $421,748. This represents 0.0% of its overall portfolio holdings.
Number of Shares
312,406Holding current value
$421,748% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LYEL
# of Institutions
123Shares Held
145MCall Options Held
2.6KPut Options Held
7.5K-
Mwg Management Ltd. Washington, DC20.2MShares$27.2 Million31.93% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$20.4 Million16.63% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$20.4 Million42.56% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$18.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.4MShares$18.1 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $335M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...